Global Inflammatory Bowel Disease Therapeutics Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI746729
- March 19, 2019
- Global
- 90 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Inflammatory Bowel Disease Therapeutics market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Inflammatory Bowel Disease Therapeutics market."
Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.
Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive the market.
In addition, strong upcoming pipeline of IBD drugs also boosts the market growth.
However, side effects of these drugs over a patients body restrain the market growth.
The global Inflammatory Bowel Disease Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Inflammatory Bowel Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbvie
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids
Segment by Application
Solid
Liquid
Table of Contents
Executive Summary
1 Inflammatory Bowel Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Therapeutics
1.2 Inflammatory Bowel Disease Therapeutics Segment by Type
1.2.1 Global Inflammatory Bowel Disease Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.2.4 Corticosteroids
1.3 Inflammatory Bowel Disease Therapeutics Segment by Application
1.3.1 Inflammatory Bowel Disease Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Solid
1.3.3 Liquid
1.4 Global Inflammatory Bowel Disease Therapeutics Market by Region
1.4.1 Global Inflammatory Bowel Disease Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Inflammatory Bowel Disease Therapeutics Market Size
1.5.1 Global Inflammatory Bowel Disease Therapeutics Revenue (2014-2025)
1.5.2 Global Inflammatory Bowel Disease Therapeutics Production (2014-2025)
2 Global Inflammatory Bowel Disease Therapeutics Market Competition by Manufacturers
2.1 Global Inflammatory Bowel Disease Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Inflammatory Bowel Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Inflammatory Bowel Disease Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Inflammatory Bowel Disease Therapeutics Production Sites, Area Served, Product Types
2.5 Inflammatory Bowel Disease Therapeutics Market Competitive Situation and Trends
2.5.1 Inflammatory Bowel Disease Therapeutics Market Concentration Rate
2.5.2 Inflammatory Bowel Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Inflammatory Bowel Disease Therapeutics Production Market Share by Regions
3.1 Global Inflammatory Bowel Disease Therapeutics Production Market Share by Regions
3.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Inflammatory Bowel Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Inflammatory Bowel Disease Therapeutics Production
...
| read more...
Related Reports
